(Q44638336)

English

Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy

scientific article published on 18 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

author name string

Yanwen Yao

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Dongmei Yuan

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Hongbing Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Xiaoling Gu

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Yong Song

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

18 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

62

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

471-479

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1347-9

21 January 2018

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1347-9

21 January 2018

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1347-9

21 January 2018

Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1347-9

21 January 2018

A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1347-9

21 January 2018

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1347-9

21 January 2018

Effects of gender on white blood cell populations and neutrophil-lymphocyte ratio following gastrectomy in patients with stomach cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1347-9

21 January 2018

Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1347-9

21 January 2018

The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1347-9

21 January 2018

The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1347-9

21 January 2018

Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1347-9

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1347-9

21 January 2018

Immunity, Inflammation, and Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1347-9

21 January 2018

Prognostic immune markers in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1347-9

21 January 2018

Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1347-9

21 January 2018

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1347-9

21 January 2018

Identifiers

10.1007/S00262-012-1347-9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44638336&oldid=2206810066"